Citation Impact
Citing Papers
Microbial Cellulose Utilization: Fundamentals and Biotechnology
2002 Standout
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
2000 Standout
Lipid Rafts As a Membrane-Organizing Principle
2009 StandoutScience
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism
2000
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor
2000 Standout
Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
2000
Myeloid Growth Factors
2011
Prevention of febrile neutropenia: use of prophylactic antibiotics
2009
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
1993
Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer
1995
Testicular cancer
2018
Doxorubicin pathways
2010 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Chemotherapy for small cell lung cancer
2003
The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interface
1997
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients
2015
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
1995
Cancer drug resistance: an evolving paradigm
2013 Standout
Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
2004
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene
1998 Nature
Multiple physiological functions for multidrug transporter P-glycoprotein?
2000
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells
1996
The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein
1999
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
2010
Molecular mechanisms of cisplatin resistance
2011 Standout
Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study
2000
Targeting multidrug resistance in cancer
2006 Standout
Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer
2005
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
P-glycoprotein—A mediator of multidrug resistance in tumour cells
1996
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)
2010
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis
2006
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Apoptosis
2002 Standout
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Clinical trials of p-glycoprotein reversal in solid tumours
1996
Due to low infection rates no routine anti‐infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine‐based first line therapy
2006
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2003 Standout
The intestinal microbiota and susceptibility to infection in immunocompromised patients
2013
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
1995
Microtubules as a target for anticancer drugs
2004 Standout
Competitive and Non‐Competitive Inhibition of the Multidrug‐Resistance‐Associated P‐glycoprotein ATPase
1997
Medical Treatment of Advanced Testicular Cancer
2008
Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma
2011
A Decade of Progress in Lymphoma: Advances and Continuing Challenges
2010
Gefitinib for non-small-cell lung cancer treatment
2011
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis
1997
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy
2009
Targeting the EGFR and the PKB pathway in cancer
2009
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
2009
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
Natural products as lead compounds in drug discovery
2013
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia
2015
Acute Myeloid Leukemia
2015 Standout
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
Prevention and Treatment of Cancer-Related Infections
2012
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Marine natural products
2015 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy
2010
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
Fludarabine in the treatment of chronic lymphocytic leukemia: a review
2009
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
2008 Standout
Chemotherapy Use among Medicare Beneficiaries at the End of Life
2003
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
2001
Cancer treatment and survivorship statistics, 2016
2016 Standout
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Cancer treatment and survivorship statistics, 2019
2019 Standout
Treating Patients With EGFR-Sensitizing Mutations: First Line or Second Line—Is There a Difference?
2013
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
2019 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Diagnostic Value of PCR Analysis of Bacteria and Fungi from Blood in Empiric-Therapy-Resistant Febrile Neutropenia
2010
Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients
2007
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
2010
Works of Michael Cullen being referenced
'Best supportive care' has had its day
2001
Antibiotic prophylaxis in neutropenic patients
2006
A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer
2005
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas
2005
Management of metastatic germ cell tumors
2008
P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site
1992
Antibiotic prophylaxis in chemotherapy‐induced neutropenia: time to reconsider
2006
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial
1986
Pharmacokinetic Study of Single Doses of Oral Fludarabine Phosphate in Patients With “Low-Grade” Non-Hodgkin's Lymphoma and B-Cell Chronic Lymphocytic Leukemia
1999
Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study
2008
The MIC regimen in non-small cell lung cancer
1993
Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)
2005
Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy
2007
Chemotherapy in small cell lung cancer: a consensus report
1989